4.3 Article

Eruptive Keratoacanthoma-Type Squamous Cell Carcinomas in Patients Taking Sorafenib for the Treatment of Solid Tumors

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Letter Dermatology

Keratoacanthomas associated with sorafenib therapy

Heidi H. Kong et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)

Article Dermatology

Inflammation of actinic keratoses subsequent to therapy with sorafenib, a multitargeted tyrosine-kinase inhibitor

M. E. Lacouture et al.

CLINICAL AND EXPERIMENTAL DERMATOLOGY (2006)

Review Immunology

TGF-β:: a mobile purveyor of immune privilege

Sharon M. Wahl et al.

IMMUNOLOGICAL REVIEWS (2006)

Review Oncology

Raf kinase as a target for anticancer therapeutics

SS Sridhar et al.

MOLECULAR CANCER THERAPEUTICS (2005)

Review Dermatology

Ultraviolet radiation and skin cancer: molecular mechanisms

MR Hussein

JOURNAL OF CUTANEOUS PATHOLOGY (2005)

Review Cell & Tissue Engineering

Effects of imatinib on normal hematopoiesis and immune activation

S Appel et al.

STEM CELLS (2005)

Article Biochemistry & Molecular Biology

Raf-independent deregulation of p38 and JNK mitogen-activated protein kinases are critical for Ras transformation

K Pruitt et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)

Review Biochemistry & Molecular Biology

Id proteins in cell cycle control and cellular senescence

Z Zebedee et al.

ONCOGENE (2001)